Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies
- PMID: 25766616
- PMCID: PMC4351408
- DOI: 10.1038/emm.2014.117
Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies
Abstract
Mammalian cells remove misfolded proteins using various proteolytic systems, including the ubiquitin (Ub)-proteasome system (UPS), chaperone mediated autophagy (CMA) and macroautophagy. The majority of misfolded proteins are degraded by the UPS, in which Ub-conjugated substrates are deubiquitinated, unfolded and cleaved into small peptides when passing through the narrow chamber of the proteasome. The substrates that expose a specific degradation signal, the KFERQ sequence motif, can be delivered to and degraded in lysosomes via the CMA. Aggregation-prone substrates resistant to both the UPS and the CMA can be degraded by macroautophagy, in which cargoes are segregated into autophagosomes before degradation by lysosomal hydrolases. Although most misfolded and aggregated proteins in the human proteome can be degraded by cellular protein quality control, some native and mutant proteins prone to aggregation into β-sheet-enriched oligomers are resistant to all known proteolytic pathways and can thus grow into inclusion bodies or extracellular plaques. The accumulation of protease-resistant misfolded and aggregated proteins is a common mechanism underlying protein misfolding disorders, including neurodegenerative diseases such as Huntington's disease (HD), Alzheimer's disease (AD), Parkinson's disease (PD), prion diseases and Amyotrophic Lateral Sclerosis (ALS). In this review, we provide an overview of the proteolytic pathways in neurons, with an emphasis on the UPS, CMA and macroautophagy, and discuss the role of protein quality control in the degradation of pathogenic proteins in neurodegenerative diseases. Additionally, we examine existing putative therapeutic strategies to efficiently remove cytotoxic proteins from degenerating neurons.
Figures
Similar articles
-
Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases.Curr Top Med Chem. 2020;20(23):2025-2043. doi: 10.2174/1568026620666200618114924. Curr Top Med Chem. 2020. PMID: 32552649 Review.
-
Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.Curr Top Dev Biol. 2006;76:89-101. doi: 10.1016/S0070-2153(06)76003-3. Curr Top Dev Biol. 2006. PMID: 17118264 Review.
-
Walking the tightrope: proteostasis and neurodegenerative disease.J Neurochem. 2016 May;137(4):489-505. doi: 10.1111/jnc.13575. Epub 2016 Mar 8. J Neurochem. 2016. PMID: 26872075 Review.
-
Protein Quality Control by Molecular Chaperones in Neurodegeneration.Front Neurosci. 2017 Apr 6;11:185. doi: 10.3389/fnins.2017.00185. eCollection 2017. Front Neurosci. 2017. PMID: 28428740 Free PMC article. Review.
-
Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.Biomed Res Int. 2014;2014:495091. doi: 10.1155/2014/495091. Epub 2014 Oct 19. Biomed Res Int. 2014. PMID: 25386560 Free PMC article. Review.
Cited by
-
A Survey on the Expression of the Ubiquitin Proteasome System Components HECT- and RBR-E3 Ubiquitin Ligases and E2 Ubiquitin-Conjugating and E1 Ubiquitin-Activating Enzymes during Human Brain Development.Int J Mol Sci. 2024 Feb 17;25(4):2361. doi: 10.3390/ijms25042361. Int J Mol Sci. 2024. PMID: 38397039 Free PMC article.
-
Protein aggregation and biomolecular condensation in hypoxic environments (Review).Int J Mol Med. 2024 Apr;53(4):33. doi: 10.3892/ijmm.2024.5357. Epub 2024 Feb 16. Int J Mol Med. 2024. PMID: 38362920 Free PMC article. Review.
-
Large-Scale Mendelian Randomization Study Reveals Circulating Blood-based Proteomic Biomarkers for Psychopathology and Cognitive Task Performance.medRxiv [Preprint]. 2024 Jan 19:2024.01.18.24301455. doi: 10.1101/2024.01.18.24301455. medRxiv. 2024. PMID: 38293198 Free PMC article. Preprint.
-
Glial senescence enhances α-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction.Cell Death Discov. 2024 Jan 26;10(1):50. doi: 10.1038/s41420-024-01816-8. Cell Death Discov. 2024. PMID: 38272865 Free PMC article.
-
Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia.Int J Mol Sci. 2024 Jan 17;25(2):1125. doi: 10.3390/ijms25021125. Int J Mol Sci. 2024. PMID: 38256197 Free PMC article.
References
-
- Ciechanover A. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin–proteasome system and onto human diseases and drug targeting. Bioorg Med Chem. 2013;21:3400–3410. - PubMed
-
- Sriram SM, Kim BY, Kwon YT. The N-end rule pathway: emerging functions and molecular principles of substrate recognition. Nat Rev Mol Cell Biol. 2011;12:735–747. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
